Tandem Diabetes Care, Inc. (NASDAQ:TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter ended September 30, 2023 and updated its financial guidance for
Tandem Diabetes Care Announces Third Quarter 2023 Financial Results lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.
Citigroup lowered shares of Tandem Diabetes Care (NASDAQ:TNDM – Free Report) from a buy rating to a neutral rating in a report issued on Friday morning, MarketBeat Ratings reports. They currently have $33.00 price objective on the medical device company’s stock, down from their prior price objective of $45.00. A number of other research analysts […]
Citigroup cut shares of Tandem Diabetes Care (NASDAQ:TNDM – Free Report) from a buy rating to a neutral rating in a report published on Friday, Marketbeat.com reports. They currently have $33.00 price objective on the medical device company’s stock, down from their prior price objective of $45.00. A number of other analysts also recently issued […]